A case study looking at Amplitude’s purchase of Command AI last year, and the new product they developed together.

Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.

Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...

Bain Capital, a global private investment firm, has proposed to acquire a significant minority shareholding in Dhoot Transmission Private Limited (DTPL) and its associate company, Dhoot Holdings ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It is a new position. Largay oversees the team’s debt and financing ...

Bain Capital purchased Kantar in 2019 Bain is a private investment firm headquartered in Boston H.I.G. Capital is a global alternative investment firm Bain Capital portfolio company Kantar Group ...

Dhoot Transmission Group, a manufacturer of automotive components, said it has sold a significant minority stake to Bain Capital, to mobilise resources for growth. The company did not disclose the ...